Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Angiogenesis and Tissue Regeneration Pathways" encompasses the coordinated set of molecular interactions and signaling events guiding the formation of new blood vessels (angiogenesis) and the subsequent growth or repair of tissues. These processes are vital for normal development, wound healing, and responses to tissue injury, but dysregulation plays a central role in diseases such as cancer (tumor angiogenesis), cardiovascular disorders, and chronic wounds. Canonical molecules involved include vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), angiopoietins, and their respective receptors, among others. Therapies targeting these components focus on either stimulating or inhibiting angiogenesis depending on the clinical context[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenesis and Tissue Regeneration Pathways.